
C-Reactive Protein Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of human C-reactive protein (CRP) in whole blood, serum, and plasma samples.
The global C-Reactive Protein Rapid Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for C-Reactive Protein Rapid Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for C-Reactive Protein Rapid Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for C-Reactive Protein Rapid Test in Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of C-Reactive Protein Rapid Test include HORIBA Ltd., Thermo Fisher Scientific, Inc., F Hoffmann-La Roche Ltd., Quest Diagnostics, Abbott, Siemens Healthineers, Danaher, Ortho Clinical Diagnostics and Laboratory Corporation of America Holdings, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for C-Reactive Protein Rapid Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C-Reactive Protein Rapid Test.
Report Scope
The C-Reactive Protein Rapid Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global C-Reactive Protein Rapid Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C-Reactive Protein Rapid Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HORIBA Ltd.
Thermo Fisher Scientific, Inc.
F Hoffmann-La Roche Ltd.
Quest Diagnostics
Abbott
Siemens Healthineers
Danaher
Ortho Clinical Diagnostics
Laboratory Corporation of America Holdings
Merck & Co., Inc.
Segment by Type
Immunoturbidimetric Assay
ELISA
Chemiluminescence immunoassay (CLIA)
Others
Segment by Application
Clinics
Hospitals
Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of C-Reactive Protein Rapid Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-Reactive Protein Rapid Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoturbidimetric Assay
1.2.3 ELISA
1.2.4 Chemiluminescence immunoassay (CLIA)
1.2.5 Others
1.3 Market by Application
1.3.1 Global C-Reactive Protein Rapid Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global C-Reactive Protein Rapid Test Market Perspective (2019-2030)
2.2 C-Reactive Protein Rapid Test Growth Trends by Region
2.2.1 Global C-Reactive Protein Rapid Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 C-Reactive Protein Rapid Test Historic Market Size by Region (2019-2024)
2.2.3 C-Reactive Protein Rapid Test Forecasted Market Size by Region (2025-2030)
2.3 C-Reactive Protein Rapid Test Market Dynamics
2.3.1 C-Reactive Protein Rapid Test Industry Trends
2.3.2 C-Reactive Protein Rapid Test Market Drivers
2.3.3 C-Reactive Protein Rapid Test Market Challenges
2.3.4 C-Reactive Protein Rapid Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C-Reactive Protein Rapid Test Players by Revenue
3.1.1 Global Top C-Reactive Protein Rapid Test Players by Revenue (2019-2024)
3.1.2 Global C-Reactive Protein Rapid Test Revenue Market Share by Players (2019-2024)
3.2 Global C-Reactive Protein Rapid Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by C-Reactive Protein Rapid Test Revenue
3.4 Global C-Reactive Protein Rapid Test Market Concentration Ratio
3.4.1 Global C-Reactive Protein Rapid Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-Reactive Protein Rapid Test Revenue in 2023
3.5 C-Reactive Protein Rapid Test Key Players Head office and Area Served
3.6 Key Players C-Reactive Protein Rapid Test Product Solution and Service
3.7 Date of Enter into C-Reactive Protein Rapid Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 C-Reactive Protein Rapid Test Breakdown Data by Type
4.1 Global C-Reactive Protein Rapid Test Historic Market Size by Type (2019-2024)
4.2 Global C-Reactive Protein Rapid Test Forecasted Market Size by Type (2025-2030)
5 C-Reactive Protein Rapid Test Breakdown Data by Application
5.1 Global C-Reactive Protein Rapid Test Historic Market Size by Application (2019-2024)
5.2 Global C-Reactive Protein Rapid Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America C-Reactive Protein Rapid Test Market Size (2019-2030)
6.2 North America C-Reactive Protein Rapid Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America C-Reactive Protein Rapid Test Market Size by Country (2019-2024)
6.4 North America C-Reactive Protein Rapid Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe C-Reactive Protein Rapid Test Market Size (2019-2030)
7.2 Europe C-Reactive Protein Rapid Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe C-Reactive Protein Rapid Test Market Size by Country (2019-2024)
7.4 Europe C-Reactive Protein Rapid Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific C-Reactive Protein Rapid Test Market Size (2019-2030)
8.2 Asia-Pacific C-Reactive Protein Rapid Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific C-Reactive Protein Rapid Test Market Size by Region (2019-2024)
8.4 Asia-Pacific C-Reactive Protein Rapid Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America C-Reactive Protein Rapid Test Market Size (2019-2030)
9.2 Latin America C-Reactive Protein Rapid Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America C-Reactive Protein Rapid Test Market Size by Country (2019-2024)
9.4 Latin America C-Reactive Protein Rapid Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C-Reactive Protein Rapid Test Market Size (2019-2030)
10.2 Middle East & Africa C-Reactive Protein Rapid Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa C-Reactive Protein Rapid Test Market Size by Country (2019-2024)
10.4 Middle East & Africa C-Reactive Protein Rapid Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HORIBA Ltd.
11.1.1 HORIBA Ltd. Company Detail
11.1.2 HORIBA Ltd. Business Overview
11.1.3 HORIBA Ltd. C-Reactive Protein Rapid Test Introduction
11.1.4 HORIBA Ltd. Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.1.5 HORIBA Ltd. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Detail
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. C-Reactive Protein Rapid Test Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 F Hoffmann-La Roche Ltd.
11.3.1 F Hoffmann-La Roche Ltd. Company Detail
11.3.2 F Hoffmann-La Roche Ltd. Business Overview
11.3.3 F Hoffmann-La Roche Ltd. C-Reactive Protein Rapid Test Introduction
11.3.4 F Hoffmann-La Roche Ltd. Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.3.5 F Hoffmann-La Roche Ltd. Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics C-Reactive Protein Rapid Test Introduction
11.4.4 Quest Diagnostics Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.4.5 Quest Diagnostics Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott C-Reactive Protein Rapid Test Introduction
11.5.4 Abbott Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Detail
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers C-Reactive Protein Rapid Test Introduction
11.6.4 Siemens Healthineers Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.6.5 Siemens Healthineers Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher C-Reactive Protein Rapid Test Introduction
11.7.4 Danaher Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.7.5 Danaher Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics C-Reactive Protein Rapid Test Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Detail
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings C-Reactive Protein Rapid Test Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.9.5 Laboratory Corporation of America Holdings Recent Development
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Company Detail
11.10.2 Merck & Co., Inc. Business Overview
11.10.3 Merck & Co., Inc. C-Reactive Protein Rapid Test Introduction
11.10.4 Merck & Co., Inc. Revenue in C-Reactive Protein Rapid Test Business (2019-2024)
11.10.5 Merck & Co., Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
HORIBA Ltd.
Thermo Fisher Scientific, Inc.
F Hoffmann-La Roche Ltd.
Quest Diagnostics
Abbott
Siemens Healthineers
Danaher
Ortho Clinical Diagnostics
Laboratory Corporation of America Holdings
Merck & Co., Inc.
Ìý
Ìý
*If Applicable.
